-
![]()
Dysfunctional Tear Syndrome: New Strategies for Diagnosis and Treatment
Dr. Raviv and his esteemed co-authors publish a comprehensive review of the state of dry eye disease, also known as dysfunctional tear syndrome, in the January 2017 Issue of Current…
-
![]()
Sutureless Explanation of BrightOcular Cosmetic Color Iris Implant with One Cut Technique
Tal Raviv MD, FACS Unstudied and unregulated cosmetic iris implants, such as the original New Color Iris, and now the Bright Ocular implant have been shown to cause severe…
-
![]()
Postop Cataract Drops
Tal Raviv, MD In 2014, the most common combination of perioperative cataract surgery eye drops—at least among my peers—included a steroid, an NSAID, and a fourth-generation fluoroquinolone antibiotic. However, over…
-
![]()
Cosmetic iris implants dubbed ‘public safety hazard
New Orleans—Cosmetic iris implants were first developed in Panama, where more than 700 people received bilateral implants between 2006 and 2010, said Tal Raviv, MD, speaking at Cornea Day at…
-
![]()
Surgeon: Patients need to be educated on dangers of cosmetic iris implants
NEW ORLEANS — Patients who are interested in receiving cosmetic iris implants to change the color of their eyes need to be educated on the ocular complications associated with the…
-
![]()
After Cataract Surgery, Hoping to Toss the Glasses
Two years ago, Anne Collins of Arlington, Va., who has been wearing glasses since fifth grade, noticed she had trouble reading the overhead street signs while driving. Cataracts, the clouding…
-
![]()
Mobile refractive screening technology yields real-world applications
Mobile refractive screening technology yields real-world applications Added benefit of portable diagnostics brings autorefraction to underserved populace New York—With a small, mobile platform, autorefractive technology (SVOne Pro, Smart Vision Labs)…
-
![]()
New Patient Check-in Health Tech: Allowing Practices to Shine
Tal Raviv, MD I’m happy to write this piece as a follow-up to my September/October 2014 ME article, Patient Check-In: Is It Time To Go Digital? In that column, I…
-
![]()
Smart Decisions
KENNETH A. BECKMAN, MD The decision that had the biggest impact on me in 2015 was to participate in the Refocus Visability Scleral Implant study for the treatment of presbyopia.…
